title: Time Savings With Transtuzumab Subcutaneous (SC) Injection Verse Trastuzumab Intravenous (IV) Infusion: A Time and Motion Study in 3 Russian Centers.
authors.affiliation: United BioSource Corporation, Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: De Cock
authors.affiliation: UBC: An Express Scripts Company, Dorval, QC, Canada.
authors.forename: Y I
authors.initials: YI
authors.lastname: Pan
authors.affiliation: UBC: An Express Scripts Company, Dorval, QC, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Tao
authors.affiliation: F. Hoffmann-La Roche Ltd., Moscow, Russia.
authors.forename: P
authors.initials: P
authors.lastname: Baidin